The stock's movement follows a statement clarifying that there is no ongoing process or assessment for a takeover, which has helped to stabilize investor sentiment as broader markets are experiencing gains.NBTX Denies Takeover Talks Amid ReportsAdditionally, Nanobiotix is a late-stage clinical biotechnology firm that aims to revolutionize cancer treatment through its proprietary nanotechnology.This focus on enhancing treatment outcomes for patients is critical as the company continues to develop its product ...